Investigación Clínica

Alteraciones del Sistema Nervioso Autónomo en la Enfermedad Cardiaca Chagásica

Diego F Dávila-Spinetti
Jose H. Donis
Gabriela Arata de Bellabarba
Vanesa Villarroel

< anterior | Página 4 de 5 | siguiente >

Referencias

1. Chagas C. Nova entidad morbida do homem: resumo general dos estudos etiológicos e clinicos. Mem Inst Oswaldo Cruz 1911; 3:219-230.
2. Puigbo JJ, Nava Rhode JR, Barrios HG, Yépez CG. A 4 year follow-up study of a rural community with endemic Chagas´disease. Bull WHO 1969; 39: 341-348.
3. Maguire JH, Of. R, Sherlock I, Guinaraes AC, Sleigh AC, Brges N, Mott KE, Weller TN. Cardiac morbidity and mortality due to Chagas´disease: prospective electrocardiographic study of a Brazilian community. Circulation 1987; 75: 1140-1145.
4. Acquatella H, Catalioti F, Gomez JR, Dávalos V, Villalobos L. Long-term control of Chagas´disease in Venezuela. Effects on serologic findings, ECG abnormalities and clinical outcome. Circulation 1987; 76: 556-562.
5. Espinoza R, Carrasco HA, Belandria F, Fuenmayor AM, Molina C, Gonzales R, Martinez O. Life expectancy analysis in patients with Chagas´disease; prognosis after one decade(1973-1983). Int J Cardiol 1985; 8: 45-56.
6. Espinoza RA, Pericchi LR, Carrasco HA, Escalante A, Martinez O, Gonzales R. Prognostic indicators of chronic chagasic cardiopathy Int J Cardiol 1991;30: 195-202
7. Carrasco HA, Parada H, Guerrero L, Duque M., Durán D, Molina C. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas´disease. Int. J. Cardiol 1994; 43,27-38.
8. Bestetti RB, Dalbo CM, Freitas OC, Teno LAC, Castilho OT, Oliveira JSM. Non-invasive predictors of mortality for patients with Chagas´heart disease: A multivariate stepwise logistic regression study. Cardiology 1994; 84: 261-267.
9. Ianni BM, Arteaga E, de Carvalho Frim C. Pereira Barreto AC, Mady C.Chagas´heart disease: Evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form. Arq Bras Cardiol 2001; 77: 59-62.
10. Rossi MA, Bestetti RB . The challenge of chagasic cardiomyopathy: The pathologic role of autonomic abnormalities, autoimmune mechanisms and microvascular changes and therapeutic implications. Cardiology 1995; 86, 1-7.
11. Tarleton RL. Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 2001; 31, 550-54.
12. Urbina J A. Chemotherapy of Chagas´disease: The how and the why. J Mol Med 77, 332-338.
13. Añez N, Carrasco H A, Parada H, Crisante G, Rojas, A, Fuenmayor C, Gonzales N, Percoco G, Borges R, Guevara P, Ramírez J L. Myocardial parasite persistence in chronic chagasic patients. Am. J. Trop. Med. Hyg. 1999; 60, 726-32.
14. Añez N, Crisante G, Rojas C, Carrasco H, Parada H, Yépez Y, Borges R, Guevara P, Ramírez JL. Detection and significance of inapparent infection in chagas disease in western Venezuela. Am J Trop Med Hyg 2001; 65: 227-232.
15. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 1993; 48: 348-357.
16. Monteon-Padilla V, Hernandez-Becerril N, Ballinas-Verdugo MA, Aranda-Frausto A, Reyes PA. Persistence of Tripanosoma cruzi in chronic chagasic cardiopathy patients. Arch Med Res 2001; 32: 39-43.
17. Texeira V de P. Hial V, Gomes RA, Castro EC, Reis M das G, Rodríguez ML, Guimaraes JV, Dos Reis MA. Correlation between adrenal central vein parsitism and heart fibrosis in chronic chagasic myocarditis. Am J Trop Med Hyg 1997; 56: 177-180.
18. Palomino SA, Aiello VD, Higuchi ML. Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol 2000;94: 571-579.
19. Pereira JB, Wilcox HP, Coura JR. The evolution of chronic chagasic cardiopathy. I The influence of parasitemia. Rev Soc Bras Med Trop 1992; 25: 101-108.
20. Leon J S, Engman D M. Autoimmunity in Chagas heart disease. Int J Parasitol 2001; 31, 554-60.
21. Iosa D, Dequattro V, De-Ping Lee D, Elkayam U, Caeiro T. Palmero H. Pathogenesis of cardiac neuro-myopathy in Chagas´ Disease and the role of the autonomic nervous system. J Auton Nervous Syst 1990;30:S83-S88.
22. Amorim DS, Manco DS, Gallo JR, Marin-Neto JA. Chagas´ heart disease as an experimental model to study cardiac autonomic function in man. Mayo Clinic Proceed. 1982; 57(Supl):46-62.
23. Oliveira JSMA. A natural model of intrinsic heart nervous denervation: Chagas´cardiopathy. Amer Heart J 1985;110:1092-8.Koberle F. Pathogenesis of Chagas ´disease. Ciba Found Symp 1974;20: 137-152.
24. Koberle F. Cardiopatia parasympathicopriva. Munchn Med Wochenschr 1959;1308-10.
25. Iosa D, De Quattro V, DE-Ping Lee, Elkayam U, Palmero H. Plasma norepinephrine in Chagas´cardioneuropathy: a marker of progressive dysautonomia. Am Heart J 1980; 117:882-87.
26. Guzetti S, Iosa D, PecisM, Bonura L, Prosdocini M, Malliani A. Impaired heart rate variability in patients with chronic Chagas´disease. Am Heart J 1991; 121:1727-28.
27. Borda ES, Sterin-Borda L. Antiadrenergic and muscarinic receptor autoantibodies in Chagas´cardiomyopathy. Int J Cardiol 1998;54:149-156.
28. Harris P. Evolution and the cardiac patient. Cardiovasc Res 1983;17:248-254.
29. Davila DF, Rosell O, Donis JH Cardiac parasympathetic abnormalities: Cause or consequence of Chagas´heart disease? Parasitology Today 1989; 5: 327-29.
30. Davila DF, Donis JH, Torres A, Gotteberg CF, Rossell O. Cardiac parasympathetic innervation in Chagas´heart disease. Medical Hypothesis 1991;35:80-84.
31. Davila DF, Donis JH, Torres A. Chagas´heart disease and neuropathy. Am Heart J 1992;124:1665-66.
32. Davila DF, Bellabarba G, Donis JH, Torres A, Rossell O J, Figueroa O, Amaro M, Vasquez CJ . Cardiac autonomic control mechanisms in Chagas´heart disease. Therapeutic implications. Medical Hypothesis 1993; 40: 33-37.
33. Davila DF, Donis JH, Torres A, Gotteberg CXF, Rossell O. Apical left ventricular aneurysms and cardiac parasympathetic innervation in Chagas´heart disease. Medical Hypothesis 1994;42:53-56.
34. Dávila D F, Inglessis G, Mazzei de Davila C, A. Chagas´ disease and the autonomic nervous system. Int J Cardiol 1998; 66: 123-27.
35. Davila, D F. The presence of Tripanosoma cruzi antigenic deposits. Am J Trop. Med. Hyg 2000; 62: 325-26.
36. Davila DF, Rossell O, Arata de Bellabarba G. Patogénesis of chronic chagas heart disease: parasite persistence and autoimmune responses versus cardiac remodeling and neurohormonal activation. Int J Parasitol 2002; 32: 107-109.
37. Davila DF Sympathetic nervous system activation in chagasic patients with congestive heart failure. J Am Coll Cardiol 2004;43:1723-1724.
38. Davila DF, Donis JH, Torres A, Ferrer J. A modified neurogenic hypothesis can explain the natural history of chronic chagas heart disease. Int J Cardiol 2004; 96:191-195.
39. Rossi L. Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment. Cardiovasc Pathol 1996;5:233-39.
40. Amorim DS, Olsen ECJ. Assessment of heart neurons in dilated (congestive cardiomyopathy) British Heart Journal 47:11-15,1982.
41. Rocha A, Neves SA, Lopes ER, Macedo VD. Acute Chagas cardiopathy. A systematic study of the intracardiac excitatory-conduction and autonomic nervous system en autochthonous case in Acre. Rev Soc Bras Med Trop 1996;29:367-371.
42. de Almeida-Ribeiro R, Lourenco Junior DM, Dias JC, Shikanai-Yasuda MA, Chapadeiro E, Lopes ER. Intracardiac autonomous nervous system in a fatal case of acute Chagas disease. Rev Soc Bras Med Trop 1993; 26:35-38.
43. Ribeiro LC, Barbosa AA Jr, Andrade ZA. Pathology of intracardiac nerves in experimental Chagas disease. Mem Inst Oswaldo Cruz 2002;97: 1019-1025.
44. Odreman RO, Davila DF, Donis JH, Torres A, Ferrer A, Inglessis I. Valsalva maneuver in chagasic patients with documented past medical history of acute chagasic myocarditis. Int J Cardiol 2004;93;163-167.
45. Davila DF, Gotteberg CF, Donis JH, Torres A, Fuenmayor AJ, Rossell O. Vagal stimulation and heart rate slowing in acute experimental chagasic myocarditis. J Auton Nervous Syst 1988;25:233-234.
46. Davila DF, Gotteberg CF, Torres A et al. Cardiac sympathetic-parasympathetic balance in rats with experimentally induced acute chagasic myocarditis. Rev Inst Med trop Sao Paulo 1995;37:155-159.
47. Torres A, Davila DF, Gotteberg CF et al. Heart rate responses to intravenous serotonin in rats with acute chagasic myocarditis. Braz J Med Biol Res 1996; 29;817-822.
48. Torres A, Davila DF, Gotteberg CF, Donis JH, Arata de Bellabarba G Ramoni-Perazzi P. Heart rate responses to a muscarinic agonist in rats with experimentally induced acute and subacute chagasic myocarditis. Rev Inst Med Trop Sao Paulo 2000;42:219-224.
49. Texeira AL, Fontoura BF, Freire-Maia L., et al. Cardiac autonomic denervation and functional response to neurotoxins during acute experimental Chagas´disease in rats. Autonomic Neuroscience 2001;89:128-132.-
50. Davila DF, Donis JH, Navas M, Fuenmayor A J, Torres A, Gottberg CF. Response of heart rate to atropine and left ventricular function in Chagas´ heart disease. Int J Cardiol 1988;21:143-56.
51. Fuenmayor AJ, Fuenmayor AM, Donis JH et al. The valsalva maneuver: a test of the funcional state of cardiac innervation in chagasic myocarditis. Int J Cardiol 1988;18:351-356.
52. Davila DF, Bellabarba G, Hernández L, Calmon G, Torres A, Donis JH, Barboza JS, Lemorvan C, Gonzales JG. Plasma norepinephrine, myocardial damage and left ventricular systolic function in Chagas´heart disease. Int J Cardiol 1995; 24:145-151.
53. Oliveira JSM. Cardiopatia chagásica experimental. Rev Goiana Med 1969;15:77-133.
54. 55. Luquez HA, Madoerry R, Amuchastegui SR, Patrignani JA. Symptomatic management of Chagas´heart disease using a beta-adrenergic blocking agent. Pren Med Argent 1968;55:774-778.
55. Davila DF, Angel F, Donis JH, Arata de Bellabarba G. Effects of metoprolol in chagasic patients with severe congestive heart failure Int J Cardiol 2002; 85:255-260.
56. Albuquerque DC, Batlouni M, Rocha RM et al. ACORDES Trial – brazilian multicentre open label study with carvedilol to demonstrated efficacy and safety in patients with chronic heart failure, including a subgroup with Chagas´disease. J Cardiac Failure 2003; 9: PS58.
57. Zicker F, Seronni Zicker EM, Oliveira JJ, Almeida Netto JC, Oliveira RM, Smith PG. Exercise electrocardiogram tests in manual workers with and without antibodies to Trypanosoma cruzi: a population-based study. Transac Royal Soc Trop Med & Hyg 1990;84:787-91.
58. Tulppo MP, Makikallio TH, Laukkanen RT, Huikuri HV. Vagal modulation of heart rate during exercise: effects of age and physical fitness. Am J Physiol 1998;274(2 Pt 2):H424-9.
59. Smith MA, Hudson DL, Graitzer HM, Raven PB. Exercise training bradycardia: the role of autonomic balance. Med Sci Sports Exerc. 1989;21:40-44.
60. Malik M, Camm AJ, Components of heart rate variability –What they really mean and what tghey really measure, Am J Cardiol 1993;72:821-22.
61. Goldberg JJ, Kim YH Ahmed MW, Kadish AH. Effects of increases in parasympathetic tone on heart rate variability. J Cardiovasc Electrophysiol 1996;7:594-2.
62. 64.- Oliveira de SA Pedrosa RC, Matheus Nascimento JH, Campos de Carvalho AC, Masuda MO. Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation 1997;96:2031-2037.
63. Rosenbaum M, Chiale PA, Scheitman D, Levin M, Elizari MV. Antibodies to beta-adrenergic receptors disclosing agonist-like properties in idiopathic dilated cardiomyopathy and Chagas´heart disease. J Cardiovasc Electrophysiol 1994;5:367-375.
64. Fu MLX. Anti- Fu MLX. Anti-M2 muscarinic receptor autoantibodies and idiopathic cardiomyopathy. Int J Cardiol 1996;54:127-135.
65. Jahns R, Boivin V, Siegmund C, Inselmann G, Lohse MJ, Boege F. Autoantibodies activating human B1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation 1999:99:649-654.
66. Liu HR, Zhao RR, Jiao XY, Wang YY, Fu M. Relationship of myocardial remodeling to the genesis of serum antibodies to cardiac beta (1)-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats. J Am Coll Cardiol 2002;39:1866-1873.